Literature DB >> 16224488

A rare case of acute myeloid leukemia with a CHIC2-ETV6 fusiongen and multiple other molecular aberrations.

F Kuchenbauer, C Schoch, E Holler, T Haferlach, W Hiddemann, S Schnittger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16224488     DOI: 10.1038/sj.leu.2403957

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  The 4q12 amplicon in malignant peripheral nerve sheath tumors: consequences on gene expression and implications for sunitinib treatment.

Authors:  Jan Zietsch; Nicolas Ziegenhagen; Frank L Heppner; David Reuss; Andreas von Deimling; Nikola Holtkamp
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

2.  Characterization of the amplicon on chromosomal segment 4q12 in glioblastoma multiforme.

Authors:  Nikola Holtkamp; Nicolas Ziegenhagen; Elke Malzer; Christian Hartmann; Alf Giese; Andreas von Deimling
Journal:  Neuro Oncol       Date:  2007-05-15       Impact factor: 12.300

3.  t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity.

Authors:  Sarah B Mueller; Paola Dal Cin; Long P Le; Dora Dias-Santagata; Jochen K Lennerz; A John Iafrate; Hetal Desai Marble; Andrew M Brunner; Matthew J Weinstock; Marlise R Luskin; Daniel J De Angelo; Richard M Stone; Valentina Nardi
Journal:  Blood Adv       Date:  2022-01-08

4.  Germline MUTYH mutations and high-grade gliomas: Novel evidence for a potential association.

Authors:  Gábor Bedics; Lili Kotmayer; Erik Zajta; Lajos László Hegyi; Edit Ágota Brückner; Hajnalka Rajnai; Lilla Reiniger; Csaba Bödör; Miklós Garami; Bálint Scheich
Journal:  Genes Chromosomes Cancer       Date:  2022-05-21       Impact factor: 4.263

5.  Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6.

Authors:  Jingyi Li; Jie Xu; Lynne V Abruzzo; Guilin Tang; Shaoying Li; M James You; Gary Lu; Elias J Jabbour; Qi Deng; Carlos E Bueso-Ramos; L Jeffrey Medeiros; C Cameron Yin
Journal:  Oncotarget       Date:  2017-12-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.